… the first time 11 C-MET PET volume-based biomarkers (TMTV, TMLU) demonstrating a …
PET/CT remains the standard technique for the nuclear medicine-based evaluation of myeloma, …

… -Pentixafor PET/CT could be a promising biomarker and superior to 18F-FDG … patients,
89Zr-DFO-daratumumab PET/CT demonstrated an excellent ability to highlight known myeloma …

… More complex PET biomarkers, such as functional volumes and tumor heterogeneity,
have also been studied or are being evaluated with promising results. First pre-therapeutic …

… as an imaging biomarker of MM, several other PET tracers have … PET/CT imaging in 8
myeloma patients (4 patients with symptomatic MM, 4 patients with SMM) the number of myeloma-…

… Working Group recently fully incorporated 18 F-FDG PET into multiple myeloma (MM) …
biomarkers extracted from this imaging at baseline. Before these 18 F-FDG PET biomarkers could …

… important prognostic impact of FDG-PET results at baseline. Indeed, four PET biomarkers
have been identified in these cohorts of patients receiving different therapeutic protocols: the …

… FDG-PET performed after three courses of chemotherapy analyzed using decrease in SUVmax
in the FDG-avid multiple myeloma patient … The prognostic PET biomarker in the study by …

… prognostic biomarkers. Therefore, we sought to identify FDG-PET/CT prognostic biomarkers
… newly diagnosed transplant eligible (NTDE) MM patients enrolled in imaging sub-studies [2,…

… Working Group (IMWG), integrating new prognostic biomarkers, with the aim of not delaying
… -PET is also useful for evaluating patients with non- or slightly secreting forms of myeloma, …

… demonstrate that PET/CT using 11 C-ACT as a biomarker of … lesions at initial diagnosis in
patients with MM. This molecular … PET/CT to help in the clinical management of MM patients …